Incomm Healthcare & Affinity Inc

Pharmagenesis develops pharmaceuticals from purified extracts of plants and other natural products that have been employed in traditional Chinese medicine for more than 4,000 years. Drug efficacy is validated by clinical trials that conform to the standards of the appropriate government regulatory agency. The company focuses on developing anticancer therapies, treatments for cancer therapy-related bone-marrow suppression and treatments for managing transplant rejection. Its drugs were initially commercialized in the high-growth markets of China and Taiwan. Pharmagenesis has a research and development facility in Palo Alto, Calif., as well as operations in Beijing; Taipei, Taiwan; and Paris.